Publications by authors named "Bryce Demoret"

Claim this Profile
C
Cutaneous Squamous Cell Carcinoma Arising Within a Previously Irradiated Mycosis Fungoides Lesion.
Shannon C South, Kimberly A Kluglein, Bryce Demoret, Richard Miller

Cureus· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDM2-Dependent Rewiring of Metabolomic and Lipidomic Profiles in Dedifferentiated Liposarcoma Models.
Andrew Patt, Bryce Demoret, Colin Stets, Kate-Lynn Bill, Philip Smith

Cancers (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Evaluation of the Concordance of Commercial Circulating Tumor DNA Alterations with Tumor-Based Sequencing across Multiple Soft Tissue Sarcoma Subtypes.
Bryce Demoret, Jeff Gregg, David A Liebner, Gabriel Tinoco, Scott Lenobel

Cancers (Basel)· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma.
Nathan D Seligson, Colin W Stets, Bryce W Demoret, Achal Awasthi, Nicholas Grosenbacher

Oncotarget· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Degree of Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma.
Kate Lynn J Bill, Nathan D Seligson, John L Hays, Achal Awasthi, Bryce Demoret

Oncologist· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition.
Douglas Spaeth-Cook, Mark Burch, Robin Belton, Bryce Demoret, Nicholas Grosenbacher

Oncotarget· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis